Redhill Biopharma Ltd banner

Redhill Biopharma Ltd
NASDAQ:RDHL

Watchlist Manager
Redhill Biopharma Ltd Logo
Redhill Biopharma Ltd
NASDAQ:RDHL
Watchlist
Price: 0.7447 USD -0.71% Market Closed
Market Cap: $3.8m

Intrinsic Value

RDHL doesn't have a meaningful market cap.

The intrinsic value for Redhill Biopharma Ltd (RDHL) under the Base Case is 9.3014 USD. Compared with the current market price of 0.7447 USD, the stock appears Undervalued by 92%.

RDHL Intrinsic Value
9.3014 USD
Undervaluation 92%
Intrinsic Value
Price $0.7447
Worst Case
Base Case
Best Case
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value $7.44
Get notified when the price drops into your buy zone
Intrinsic Value $9.3
Margin of Safety 20% $7.44
Current Price $0.74
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about RDHL?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is RDHL valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Redhill Biopharma Ltd.

Explain Valuation
Alternatives to RDHL

Wall St
Price Targets

Dividends

Redhill Biopharma Ltd
does not pay dividends
Shareholder Yield

Competitive Landscape

What is the Intrinsic Value of one RDHL stock?

The intrinsic value for Redhill Biopharma Ltd (RDHL) under the Base Case is 9.3014 USD.

Is RDHL stock undervalued or overvalued?

Compared with the current market price of 0.7447 USD, the stock appears Undervalued by 92%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett